Synthesis and Distribution of Drugs of Abuse and Related Compounds

SOL #: 75N95022R00016SBPre-SolicitationSole Source

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NIDA
Bethesda, MD, 20892, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in the Physical (541715)

PSC

Health R&D Services; Health Care Services; Basic Research (AN11)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Timeline

1
Posted
May 13, 2026
2
Response Deadline
May 28, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute on Drug Abuse (NIDA), part of NIH, has issued a Notice of Intent to Award a Sole Source Modification to RESEARCH TRIANGLE INSTITUTE for the contract "Synthesis and Distribution of Drugs of Abuse and Related Compounds" (75N95022D00016). The modification will increase the contract's maximum value by $3,718,289, raising it from $14,004,330 to $17,722,619. This action aims to prevent disruption of critical support services for substance use research and address increased demand for drug products for clinical trials.

Scope of Work

The existing contract provides essential services including:

  • Producing and distributing labeled and unlabeled drugs of abuse and research compounds.
  • Analyzing, testing, and maintaining the purity of drug supply inventory.
  • Replenishing existing drug supply and acquiring new chemical compounds.
  • Maintaining and updating the NIDA drug supply database (DISCS).

Contract Details

  • Type: Sole Source Modification to a Single Award IDIQ
  • Current Contractor: RESEARCH TRIANGLE INSTITUTE
  • Original Contract Set-Aside: Total Small Business Set-Aside (FAR 19.5) under NAICS 541715 (Small Business Size Standard: 1,000 employees)
  • Value Increase: $3,718,289
  • New Maximum Value: $17,722,619
  • Ordering Period: June 9, 2022, to June 8, 2027 (unchanged)
  • Statutory Authority: 10 U.S.C. 3204(a)(1) or 41 U.S.C. 3304(a)(1) and FAR 6.103-1 (Only one responsible source).

Response Information

This is not a request for competitive proposals. However, interested parties may:

  • Identify their interest.
  • Submit capability statements.
  • Submit objections to the proposed modification. Responses will be considered to determine if a competitive procurement is feasible.

Key Dates & Contacts

  • Response Due: May 28, 2026, by 1:00 p.m. EDT
  • Published Date: May 13, 2026
  • Primary Contact: Shaun Rostad (shaun.rostad@nih.gov)

People

Points of Contact

Joshua T. LazarusSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Pre-Solicitation
Posted: May 13, 2026
Synthesis and Distribution of Drugs of Abuse and Related Compounds | GovScope